Bariatric surgery for obesity and diabetes

Archives of Iranian Medicine

Volumn 16, Issue 3, 2013, Pages 182-186

  Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bariatric surgery; Diabetes; Obesity

Indexed keywords

BARIATRIC SURGERY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSLIPIDEMIA; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIFE EXPECTANCY; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING; SURGICAL MORTALITY; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; UNITED STATES; WORLD HEALTH;

EID: 84874625486     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. World Health Organization. Overweight and Obesity. Factsheet no. 311. Geneva (Switzerland). World Health Organization; 2006.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303: 235-241.
3. Hosseinpanah F, Barzin M, Eskandary PS, Mirmiran P, Azizi F. Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC Public Health. 2009; 9: 426.
4. Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M, et al. Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-communicable Diseases. Metab Syndr Relat Disord. 2010; 8: 209-213.
5. O'Brien PE. Bariatric surgery: mechanisms, indications, and outcomes. J Gastroenterol Hepatol. 2010; 25: 1358-1365.
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444: 860-867.
7. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011; 121(6): 2111-2117.
8. Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012; 142(5): 1100-1101.
9. Glant M, Raz I. Present and future: pharmacologic treatment of obesity. J Obes. 2011; 2011: 636181.
10. Dushay J, Gao C, Gopalakrishnan GS, Crawley M, Mitten EK, Wilker E, et al. Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes. Diabetes Care. 2012; 35: 4-11.
11. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, et al. Weight and metabolic outcomes after two years on a low-carbo-hydrate versus low-fat diet: a randomized trial. Ann Intern Med. 2010; 153: 147-157.
12. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009; 360: 859-873.
13. Barte JC, ter Bogt NC, Bogers RP, Teixeira PJ, Blissmer B, Mori TA, et al. Maintenance of weight loss after lifestyle interventions for overweight and obesity: a systematic review. Obes Rev. 2010; 11: 899-906.
14. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001; 74: 579-584.
15. Eldar S, Heneghan HM, Brethauer SA, Schauer PR. Bariatric surgery for treatment of obesity. Int J Obes (Lond). 2011; 35: 16-21.
16. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009; 19: 1605-1611.
17. Dumon KR, Murayama KM. Bariatric surgery outcomes. Surg Clin N Am. 2011; 91: 1313-1338.
18. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299: 316-323.
19. O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006; 144: 625-633.
20. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357: 741-752.
21. Garza CA, Pellikka PA, Somers VK, Sarr MG, Collazo-Clavell ML, Korenfeld Y, et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol. 2010; 105: 550-556.
22. Algahim MF, Lux TR, Leichman JG, Boyer AF, Miller CC, Laing ST, et al. Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med. 2010; 123: 549-555.
23. Nerla R, Tarzia P, Sestito A, Di Monaco A, Infusino F, Matera D, et al. Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvascular function. Nutr Metab Cardiovasc Dis. 2012; 22: 626-634.
24. Heneghan HM, Meron-Eldar S, Brethauer SA, Schauer PR, Young JB. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011; 108: 1499-1507.
25. Benraouane F, Litwin SE. Reductions in cardiovascular risk after bariatric surgery. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol. 2011; 26: 555-561.
26. Harati H, Hadaegh F, Momenan AA, Ghanei L, Bozorgmanesh MR, Ghanbarian A, et al. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med. 2010; 38: 628-636.
27. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012; 379: 2300-2311.
28. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: a systematic review and meta-analysis. Am J Med. 2009; 122: 248-256.
29. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Poth-ier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366: 1567-1576.
30. Laferrère B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond). 2011; 35: 22-25.
31. Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastro-intest Surg. 2009; 13: 793-797.
32. Pajecki D, Dalcanalle L, Souza de Oliveira CP, Zilberstein B, Halp-ern A, Garrido AB Jr, et al. Follow-up of Roux-en-Y gastric bypass patients at five or more years postoperatively. Obes Surg. 2007; 17: 601-607.
33. Chowbey PK, Dhawan K, Khullar R, Sharma A, Soni V, Baijal M, et al. Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results. Obes Surg. 2010; 20: 1340-1347.
34. Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005; 28: 2406-2411.
35. Jamal M, Wegner R, Heitshusen D, Liao J, Samuel I. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a six-year analysis of data. Surg Obes Relat Dis. 2011; 7: 473-479.
36. Segal JB, Clark JM, Shore AD, Dominici F, Magnuson T, Richards TM, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009; 19: 1646-1656.
37. Navarro-Díaz M, Serra A, Romero R, Bonet J, Bayés B, Homs M, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: a long-term follow-up. J Am Soc Nephrol. 2006; 17: 213-217.
38. Agrawal V, Khan I, Rai B, Krause KR, Chengelis DL, Zalesin KC, et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol. 2008; 70: 194-202.
39. Alexander JW, Goodman HR, Hawver LR, Cardi MA. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis. 2009; 5: 237-241.
40. de Jong JR, Besselink MG, van Ramshorst B, Gooszen HG, Smout AJ. Effects of adjustable gastric banding on gastroesophageal reflux and esophageal motility: a systematic review. Obes Rev. 2010; 11: 297-305.
41. Foster A, Laws HL, Gonzalez QH, Clements RH. Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass. J Gastrointest Surg. 2003; 7: 750-753.
42. Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis. 2010; 28: 274-279.
43. Vincent HK, Ben-David K, Cendan J, Vincent KR, Lamb KM, Stevenson A. Effects of bariatric surgery on joint pain: a review of emerging evidence. Surg Obes Relat Dis. 2010; 6: 451-460.
44. Crémieux PY, Ledoux S, Clerici C, Cremieux F, Buessing M. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. 2010; 20: 861-870.
45. Assimakopoulos K, Karaivazoglou K, Panayiotopoulos S, Hyphantis T, Iconomou G, Kalfarentzos F. Bariatric surgery is associated with reduced depressive symptoms and better sexual function in obese female patients: a one-year follow-up study. Obes Surg. 2011; 21: 362-366.
46. Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, We-del H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009; 10: 653-662.
47. Strohmayer E, Via MA, Yanagisawa R. Metabolic management following bariatric surgery. Mt Sinai J Med. 2010; 77: 431-445.
48. Kasalicky M, Michalsky D, Housova J, Haluzik M, Housa D, Haluzikova D, et al. Laparoscopic sleeve gastrectomy without an over-sewing of the staple line. Obes Surg. 2008; 18: 1257-1262.
49. Sammour T, Hill AG, Singh P, Ranasinghe A, Babor R, Rahman H. Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Obes Surg. 2010; 20: 271-275.
50. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007; 132: 2253-2271.
51. van Hout GC, Boekestein P, Fortuin FA, Pelle AJ, van Heck GL. Psychosocial functioning following bariatric surgery. Obes Surg. 2006; 16: 787-794.
52. Terranova L, Busetto L, Vestri A, Zappa MA. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012; 22: 646-653.
53. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and metaanalysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011; 253: 1-4.
54. Statistical Brief #23, Baratric Surgery Utilization and Outcomes in 1998 and 2004. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2007.
55. Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carls-son B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012; 367(8): 695-704.
56. Reoch J, Mottillo S, Shimony A, Filion KB, Christou NV, Joseph L, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 2011; 146: 1314-1322.
57. Finkelstein EA, Trogdon JG, Cohen JW. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. 2009; 28: 822-831.
58. Powers KA, Rehrig ST, Jones DB. Financial impact of obesity and bariatric surgery. Med Clin North Am. 2007; 91: 321-328.
59. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. F as in fat: how obesity policies are failing in America. Issue report. Princeton: Robert Wood Johnson Foundation; 2009.
60. Clegg A, Colquitt J, Sidhu M. Clinical and cost-effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes. 2003; 27: 1167-1177.
61. Gastrointestinal surgery for severe obesity. Consensus Statement. 1991; 9: 1-20.
62. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005; 1: 371-381.
63. Richards NG, Beekley AC, Tichansky DS. The economic costs of obesity and the impact of bariatric surgery. Surg Clin North Am. 2011; 91: 1173-1180.
64. Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009; 9: 186.
65. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006; 6: 158.
66. Janghorbani M, Amini M, Willett WC, Mehdi Gouya M, Delavari A, Alikhani S, et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity (Silver Spring). 2007; 15(11): 2797-2808.
67. Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity, and the associated factors in an urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007; 8(1): 3-10.
68. Sepanlou SG, Kamangar F, Poustchi H, Malekzadeh R. Reducing the burden of chronic diseases: a neglected agenda in Iranian healthcare system, requiring a plan for action. Arch Iran Med. 2010; 13(4): 340-350.
69. Bahadoran Z, Mirmiran P, Golzarand M, Hosseini-Esfahani F, Azizi F. Fast food consumption in Iranian adults; dietary intake and cardiovascular risk factors: Tehran Lipid and Glucose Study. Arch Iran Med. 2012; 15(6): 346-351.